Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apple of sodom extract is a **non-specific botanical extract term** that has been used for more than one plant-derived preparation in the literature and product databases, most notably extracts associated with **Calotropis procera** and, in older anticancer and dermatology contexts, glycoalkaloid-containing extracts associated with **Solanum sodomeum** marketed as **Curaderm**. As a result, it does not denote a single well-defined active pharmaceutical ingredient with a single established mechanism of action. Depending on source material and formulation, reported bioactivities include cytotoxic, anti-inflammatory, antioxidant, antimicrobial, and keratolytic effects, but these effects are driven by complex mixtures of phytochemicals rather than a clearly validated single molecular target. The term is therefore better treated as an ambiguous botanical preparation than as a specific pharmaceutical drug entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on apple of sodom extract.